Cytokines such as IL-3, GM-CSF, and FLT3L protect AML cells from the cytotoxicity mediated by CAR-T cells, as well as the serum of patients treated with CAR-T cells obtained in correspondence of in vivo peak of CAR-T cells [152]. The gene discussed is CSF2; the disease is acute myeloid leukemia.